Injection · Intramuscular
Influenza A Virus A/Missouri/11/2025 (H1n1) Recombinant Hemagglutinin Antigen, Influenza A Virus A/Darwin/1415/2025 (H3n2) Recombinant Hemagglutinin Antigen, And Influenza B Virus B/Pennsylvania/14/2025 Recombinant Hemagglutinin Antigen
Brands: Flublok Trivalent Northern Hemisphere · Influenza A Virus A/Missouri/11/2025 (H1n1) Recombinant Hemagglutinin Antigen + Influenza A Virus A/Darwin/1415/2025 (H3n2) Recombinant Hemagglutinin Antigen + Influenza B Virus B/Pennsylvania/14/2025 Recombinant Hemagglutinin Antigen
0 ACTIVE SUPPLIERS - US
openFDA · updated weekly
US1 NDCs
0 active makers
0 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC -
RxCUI (US)1657131
US makers1 labelers
Packages1
DEA / ScheduleNone
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it0 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Sanofi Vaccines US Inc. | unknown | 1 | EXITED 2027 |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.